Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepakro
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous, Oral
01
Overview
Hepakro is a brand name used by Croise Pharma for a range of hepatoprotective formulations. These include Hepakro Syrup (an Ayurvedic preparation), Hepakro Tablets (containing L-ornithine L-aspartate and pancreatin), Hepakro-SM Tablets (containing metadoxine, silymarin, L-ornithine L-aspartate, pyridoxine, and folic acid), Hepakro-Forte Capsules (containing L-ornithine L-aspartate, silymarin, pancreatin, lecithin, and B-complex vitamins), and Hepakro Injection (containing L-ornithine L-aspartate). Additionally, Hepakro FT is marketed as a formulation of ursodeoxycholic acid. These products are primarily indicated for liver protection, hepatic encephalopathy, liver cirrhosis, and other liver disorders.
- Brand names
- HepakroHepakro FTHepakro-ForteHepakro-SM
02
Targets
CPS1 (Carbamoyl phosphate synthetase I)GPBAR1GR (Glucocorticoid receptor)GLUL (Glutamine synthetase)OTC (Ornithine carbamoyltransferase)
Beyond the preview
Go deeper on Hepakro.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepakro.